Agenus Inc. buy melinda
Start price
18.01.20
/
50%
€3.48
Target price
04.11.21
€4.40
Performance (%)
4.79%
End price
05.11.21
€3.65
Summary
This prediction ended on 05.11.21 with a price of €3.65. With a performance of 4.79%, the BUY prediction by melinda for Agenus Inc. closed with a slight gain. melinda has 50% into this predictionAgenus is a biotechnology company focused on developing immunotherapies to treat cancer and other diseases. The company's product pipeline includes checkpoint inhibitors, which work by blocking proteins that help cancer cells evade detection by the immune system, as well as other immunotherapies designed to stimulate the body's immune response to tumors. Agenus has collaborations with large pharmaceutical companies including Merck, Incyte, and Gilead, and is actively working on bringing its products to market through clinical trials and regulatory approval. The company is listed on the NASDAQ stock exchange under the ticker symbol AGEN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Agenus Inc. | - | - | -73.381% | -81.044% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
Comments by melinda for this prediction
In the thread Agenus Inc. diskutieren
Buy with target price 4.4
In the thread Trading Agenus Inc.
Die von melinda gewählte maximale Laufzeit wurde überschritten